Peptic Ulcer Disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Helicobacter pylori infection disrupts the mucosal barrier by increasing gastric acid secretion and causing chronic inflammation, leading to mucosal erosion and ulceration.

• Secondary mechanism: NSAID use inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis, which impairs mucosal blood flow and bicarbonate secretion, compromising the gastric mucosal defense.

• Key complication: Perforation occurs when ulcers penetrate the full thickness of the gastric or duodenal wall, leading to peritonitis, severe abdominal pain, and potential sepsis, necessitating emergency surgical intervention.

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Key past medical history: Diagnosed with Helicobacter pylori infection, history of NSAID use for chronic back pain, hypertension, type 2 diabetes

• Current medications: Lisinopril, Metformin, Ibuprofen

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and vomiting blood

• Key symptoms: Nausea, melena, severe epigastric pain, dizziness, fatigue

• Vital signs: Blood pressure 90/60 mmHg, heart rate 120 bpm, respiratory rate 28 breaths per minute, temperature 101°F, oxygen saturation 88% on room air

Section 1

The initial assessment reveals a critically ill patient with signs of hypovolemic shock, likely due to gastrointestinal bleeding and potential perforation. On examination, the patient presents with a rigid abdomen, guarding, and rebound tenderness, indicative of peritoneal irritation. Laboratory investigations show a hemoglobin level of 7.5 g/dL, significantly lower than normal, confirming acute blood loss anemia. Elevated white blood cell count at 16,000/mm³ suggests an inflammatory response, while a lactate level of 4.5 mmol/L indicates tissue hypoperfusion and metabolic acidosis. The elevated blood urea nitrogen (BUN) and creatinine levels further support renal hypoperfusion, consistent with prerenal acute kidney injury secondary to volume depletion.

Imaging studies, including an abdominal X-ray, reveal free air under the diaphragm, confirming perforation of the gastrointestinal tract. An urgent esophagogastroduodenoscopy (EGD) is performed, revealing a large bleeding duodenal ulcer with evidence of active spurting, classifying it as a Forrest I ulcer, which carries a high risk for further bleeding. Additionally, the EGD findings show surrounding tissue necrosis and signs of potential sepsis.

Given these findings, the patient is immediately prepped for emergency laparotomy to address the perforation and control the bleeding. The surgical team is alerted to the possibility of further complications, such as septic shock and multi-organ dysfunction. The patient's hemodynamic instability requires aggressive resuscitation with intravenous fluids and blood products, alongside broad-spectrum antibiotics to manage the risk of sepsis. This critical juncture demands advanced clinical reasoning to anticipate postoperative complications and prioritize interventions to stabilize the patient's condition, including ongoing monitoring of vital signs and laboratory parameters to guide further treatment decisions.

Section 2

As the surgical team progresses with the emergency laparotomy, they encounter a severely inflamed and necrotic section of the duodenum surrounding the perforated ulcer. The ulcer is successfully sutured, and a Graham patch is applied to reinforce the repair. However, intraoperative findings reveal extensive contamination of the peritoneal cavity with gastric contents, necessitating thorough irrigation and drainage to minimize the risk of subsequent peritoneal infection. Despite these interventions, the patient’s condition remains precarious, characterized by persistent hemodynamic instability.

Postoperative monitoring in the intensive care unit reveals a concerning change in the patient’s status. The vital signs indicate persistent hypotension with blood pressure readings hovering around 85/50 mmHg, even after aggressive fluid resuscitation and transfusion of two units of packed red blood cells. The heart rate remains elevated at 125 beats per minute, and the patient exhibits tachypnea with a respiratory rate of 28 breaths per minute. New laboratory results show a further drop in hemoglobin to 6.8 g/dL, despite transfusions, suggesting ongoing bleeding or dilutional effects from the fluids. Additionally, the lactate level has risen to 5.2 mmol/L, signifying worsening tissue hypoperfusion.

In light of these developments, the clinical team must reevaluate the treatment strategy, considering the potential for occult bleeding, refractory shock, or evolving septic shock. The decision is made to initiate vasopressor support with norepinephrine to stabilize the blood pressure, alongside continuous monitoring of central venous pressure and mixed venous oxygen saturation to guide fluid management. Broad-spectrum antibiotic coverage is intensified, and a repeat EGD is scheduled to reassess the integrity of the ulcer repair and identify any additional sources of bleeding. This complex scenario demands advanced clinical reasoning to balance aggressive intervention with the risk of exacerbating the patient’s fragile state, highlighting the critical need for ongoing evaluation and adjustment of the treatment plan.

Section 3

As the clinical team continues to manage the patient's precarious condition, new diagnostic results return, shedding light on potential underlying issues. The repeat endoscopy (EGD) reveals a small amount of fresh bleeding at the site of the ulcer repair, suggesting a partial disruption of the suture line or an adjacent bleeding vessel. However, this finding does not fully account for the significant drop in hemoglobin and the patient's hemodynamic instability. Concurrently, a contrast-enhanced CT scan of the abdomen and pelvis identifies a discrete collection of fluid in the right upper quadrant, which is concerning for a developing abscess or localized peritoneal infection. This complicates the clinical picture, introducing the possibility of a secondary source of sepsis contributing to the ongoing shock state.

In response to these findings, the team deliberates on the optimal course of action. Given the possibility of secondary infection, interventional radiology is consulted for potential percutaneous drainage of the fluid collection, aiming to reduce the infectious burden without subjecting the patient to another invasive surgical procedure. Additionally, the team considers the need for a more aggressive approach to hemostasis at the ulcer site, balancing the risks of reoperation against the patient's current critical status. Hemodynamic support is optimized with norepinephrine titration, and the addition of vasopressin is contemplated to achieve better vascular tone and perfusion. Meanwhile, the laboratory team is asked to expedite coagulation studies, as coagulopathy could further complicate the bleeding risk.

These nuanced developments underscore the complexity of the patient's condition, necessitating a multifaceted strategy that integrates surgical, medical, and interventional expertise. The team remains vigilant, aware that each intervention must be carefully weighed against the potential for further destabilization. This scenario demands advanced clinical reasoning, as the balance between aggressive treatment and the preservation of remaining physiological reserves becomes ever more precarious. The next phase of the patient's journey hinges on the team's ability to swiftly and accurately interpret evolving clinical data, ensuring that each decision aligns with the overarching goal of stabilizing the patient while anticipating and mitigating additional complications.

Section 4

As the clinical team continues to manage the patient's condition, new complications arise. Just hours after the initial interventions, the patient's status changes unexpectedly. Vital signs reveal a concerning trend: the blood pressure, which had been marginally stable on norepinephrine, begins to plummet, with readings dropping to 78/46 mmHg. Heart rate climbs to 132 beats per minute, and the patient becomes increasingly tachypneic, with a respiratory rate of 28 breaths per minute. Oxygen saturation dips to 89% on a non-rebreather mask, prompting the team to escalate respiratory support. The patient's skin is noted to be cool and clammy, with mottling visible on the extremities, indicating a worsening perfusion state.

Lab results provide further insight into the deterioration. The expedited coagulation studies reveal a rising INR of 2.3 and a prolonged activated partial thromboplastin time (aPTT), suggestive of a developing coagulopathy. Concurrently, a repeat hemoglobin level drops further to 6.8 g/dL, reinforcing concerns about ongoing blood loss. The white blood cell count has spiked to 18,000/mm³ with a left shift, supporting the suspicion of an infectious process. Lactate levels are significantly elevated at 5.2 mmol/L, indicating lactic acidosis and systemic hypoperfusion.

In response to these alarming developments, the team is faced with critical decisions. The worsening coagulopathy necessitates the urgent administration of fresh frozen plasma and vitamin K to correct clotting abnormalities. Given the drop in hemoglobin, additional blood transfusions are arranged to address the anemia. The interventional radiology team is mobilized urgently to perform percutaneous drainage of the fluid collection, as the risk of sepsis and further decompensation looms large. Meanwhile, vasopressin is added to the hemodynamic support regimen in an attempt to stabilize vascular tone. The team remains in high alert, aware that each intervention carries significant risk, yet is essential to prevent further decline. The next phase hinges on the efficacy of these measures to arrest the downward spiral, underscoring the critical need for precise and timely clinical judgments.

Section 5

As the team executes the critical interventions, the patient's status remains precarious. Despite the administration of fresh frozen plasma and vitamin K, the coagulation profile shows only marginal improvement; the INR decreases to 1.9, and the aPTT remains prolonged. The persistence of coagulopathy raises suspicion of an underlying hepatic dysfunction that may be contributing to the clotting abnormalities. Further investigation reveals a surge in liver enzymes, with ALT and AST levels tripling from baseline, suggesting an acute insult to the liver, possibly due to hypoperfusion or drug-induced injury.

In parallel, the interventional radiology team successfully drains an abscess identified in the abdominal imaging, yielding purulent fluid that is sent for culture. The immediate post-procedural period sees a slight stabilization in vitals; however, the patient's blood pressure remains tenuous, hovering around 85/50 mmHg with the addition of vasopressin. The patient's tachycardia persists at 128 bpm, and though oxygen saturation improves slightly to 91% with high-flow nasal cannula, the respiratory effort remains labored.

The clinical team grapples with the evolving complexity of the case. The rise in liver enzymes, coupled with the persistent coagulopathy, suggests a multifactorial crisis involving potential ischemic hepatitis. Meanwhile, the culture results from the drained abscess are pending, leaving the infectious etiology unresolved. Given the elevated white cell count and ongoing lactic acidosis, broad-spectrum antibiotics are continued empirically, but the need for targeted therapy looms as a critical next step. The patient's course underscores the necessity for vigilant monitoring and adaptive strategies, recognizing the delicate balance between aggressive intervention and the risk of exacerbating organ dysfunction. As night falls, the team prepares for a potential transition to a higher level of care, including the possibility of initiating continuous renal replacement therapy should the patient's renal function deteriorate further in the face of multi-organ stress.